Coronavirus Treatment Developer Gilead Reportedly in Crosshairs of Iranian Hackers

Hostile actors using Iran-linked hosting servers and web domains are said to have repeatedly attempted to breach Gilead's systems. The US company's drug is the only one proven to help COVID-19 carriers

 

Photo: Reuters

US pharmaceutical company Gilead Sciences, considered a frontrunner in the race to develop a coronavirus treatment, was the target of repeated attacks by Iranian hackers over the past few weeks, according to reports.

It was not known whether the company's systems had been breached. Unidentified cybersecurity researchers were quoted by Reuters as saying that the hackers used Iran-linked hosting servers and web domains.  

Gilead has been in the spotlight recently as its drug Remdesivir is the only treatment proven to help COVID-19 carriers. The US Food and Drug Administration recently authorized emergency use of the drug to treat severe cases.

On May 5, the UK’s National Cyber Security Centre and the US Cybersecurity and Infrastructure Security Agency issued a joint advisory warning that medical research organizations and healthcare bodies have become main targets of nation-state hackers amid the coronavirus crisis.

 

You might be interested also

Photo: Bigstock

Russia’s Geopolitics and Strategy in the Future

Commentary:  The last complete Russian military doctrine was conceived during a very different phase of the East-West confrontation, before Russia's participation in the war in Syria and hence even before the new projection of Russian power onto the Mediterranean. In any case, 2020 is an end point for Russian military planners. Many things will be decided in the relations between East and West based on the military doctrine developed this year